Skip to Main Content

Paper Details

Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates.
PLoS Biol
13
2022
COVID-19, Coronavirus Disease, Fc, Fc receptor, SARS, SARS-CoV, SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2, T cells, T-cell
Author NameAffiliation
Matthew J GormanRagon Institute of MGH
Douglas A LauffenburgerMassachusetts Institute of Technology
Douglas A LauffenburgerMassachusetts Institute of Technology
Dan H BarouchRagon Institute of MGH
Dan H BarouchCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School
Dan H Barouch
Galit AlterRagon Institute of MGH
  • 1 - 7

Datasets

Release 1.2